Cargando…

Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”

Detalles Bibliográficos
Autor principal: Saba, Corey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511082/
https://www.ncbi.nlm.nih.gov/pubmed/35856458
http://dx.doi.org/10.1111/jvim.16490
_version_ 1784797584816078848
author Saba, Corey
author_facet Saba, Corey
author_sort Saba, Corey
collection PubMed
description
format Online
Article
Text
id pubmed-9511082
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95110822022-09-30 Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” Saba, Corey J Vet Intern Med Letters to the Editor John Wiley & Sons, Inc. 2022-07-20 2022 /pmc/articles/PMC9511082/ /pubmed/35856458 http://dx.doi.org/10.1111/jvim.16490 Text en © 2022 The Author. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC. on behalf of the American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Saba, Corey
Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
title Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
title_full Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
title_fullStr Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
title_full_unstemmed Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
title_short Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
title_sort response to letter regarding “alvac‐fil2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: a pilot study”
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511082/
https://www.ncbi.nlm.nih.gov/pubmed/35856458
http://dx.doi.org/10.1111/jvim.16490
work_keys_str_mv AT sabacorey responsetoletterregardingalvacfil2afelineinterleukin2immunomodulatorasatreatmentforsarcoidsinhorsesapilotstudy